# Emiliano Calvo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/emiliano-calvo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,761 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 60 |
| i10-index | 210 |
| Last Known Institution | Star Technology and Research (United States) |
| OpenAlex ID | https://openalex.org/A5053069942 |
| ORCID iD | https://orcid.org/0000-0003-4921-829X |
| Works | 693 |

## Researcher papers

- [Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort](https://scholariq.org/papers/nivolumab-monotherapy-and-nivolumab-plus-ipilimumab-in-recurrent-small-cell-lung/)
- [Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial](https://scholariq.org/papers/ramucirumab-plus-pembrolizumab-in-patients-with-previously-treated-advanced-non/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

## Researcher university

- [Star Technology and Research (United States)](https://scholariq.org/institutions/star-technology-and-research-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.